We would like to express our special thanks to the staff of Tha Luang, Tha Wung, Pattnanikom, and Sanamchaikate hospitals for providing data and resources in our study.
Glaziou P, Floyd K, Raviglione MC, 2018. Global Epidemiology of Tuberculosis. Seminars in Respiratory and Critical Care Medicine. New York, NY: Thieme Medical Publishers, 271–285.
Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, Dye C, 2003. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 163: 1009–1021.
Aaron L, Saadoun D, Calatroni I, Launay O, Memain N, Vincent V, Marchal G, Dupont B, Bouchaud O, Valeyre D, 2004. Tuberculosis in HIV-infected patients: a comprehensive review. Clin Microbiol Infect 10: 388–398.
Havlir DV, Getahun H, Sanne I, Nunn P, 2008. Opportunities and challenges for HIV care in overlapping HIV and TB epidemics. JAMA 300: 423–430.
Bureau of Tuberculosis, Ministry of Public Health, 2018. National Tuberculosis Control Programme Guideline, Thailand, 2018. Bangkok, Thailand: Ministry of Public Health.
International Health Policy Program, Ministry of Public Health, 2017. Disability-Adjusted Life Years: DALYs. Nonthaburi, Thailand: Ministry of Public Health.
Department of Economic, United Nations, 2018. Population of Urban and Rural Areas at Mid-Year (Thousands) and Percentage Urban, 2018. Available at: https://population.un.org/wup/Download/. Accessed September 28, 2019.
Tangcharoensathien V, Witthayapipopsakul W, Panichkriangkrai W, Patcharanarumol W, Mills A, 2018. Health systems development in Thailand: a solid platform for successful implementation of universal health coverage. Lancet 391: 1205–1223.
Pengpid S, Peltzer K, Puckpinyo A, Tiraphat S, Viripiromgool S, Apidechkul T, Sathirapanya C, Leethongdee S, Chompikul J, Mongkolchati A, 2016. Knowledge, attitudes, and practices about tuberculosis and choice of communication channels in Thailand. J Infect Dev Ctries 10: 694–703.
Cai J, Wang X, Ma A, Wang Q, Han X, Li Y, 2015. Factors associated with patient and provider delays for tuberculosis diagnosis and treatment in Asia: a systematic review and meta-analysis. PLoS One 10: e0120088.
The Healthcare Accreditation Institute (Public Organization), 2017. Hospital Accreditation Status, 2017. Available at: http://www.ha.or.th/EN/Article/The%20hospital%20is%20accredited. Accessed September 28, 2019.
Thai Health Coding Center, 2011. Classification Criteria for Healthcare Center under Ministry of Public Health Levels According to Geographic Information System (GIS). Available at: http://www.thcc.or.th/download/GIS54.pdf. Accessd September 28, 2019.
Wen Y, Zhang Z, Li X, Xia D, Ma J, Dong Y, Zhang X, 2018. Treatment outcomes and factors affecting unsuccessful outcome among new pulmonary smear positive and negative tuberculosis patients in Anqing, China: a retrospective study. BMC Infect Dis 18: 104.
Muture BN, Keraka MN, Kimuu PK, Kabiru EW, Ombeka VO, Oguya F, 2011. Factors associated with default from treatment among tuberculosis patients in Nairobi province, Kenya: a case control study. BMC Public Health 11: 696.
Melese A, Zeleke B, 2018. Factors associated with poor treatment outcome of tuberculosis in Debre Tabor, northwest Ethiopia. BMC Res Notes 11: 25.
Berhe G, Enquselassie F, Aseffa A, 2012. Treatment outcome of smear-positive pulmonary tuberculosis patients in Tigray Region, Northern Ethiopia. BMC Public Health 12: 537.
de Albuquerque MdeF, Ximenes RA, Lucena-Silva N, Souza WV, Dantas AT, Dantas OM, Rodrigues LC, 2007. Factors associated with treatment failure, dropout, and death in a cohort of tuberculosis patients in Recife, Pernambuco State, Brazil. Cad Saúde Pública 23: 1573–1582.
Jakubowiak W, Bogorodskaya E, Borisov E, Danilova D, Kourbatova E, 2007. Risk factors associated with default among new pulmonary TB patients and social support in six Russian regions. Int J Tuberc Lung Dis 11: 46–53.
Muñoz-Sellart M, Cuevas L, Tumato M, Merid Y, Yassin M, 2010. Factors associated with poor tuberculosis treatment outcome in the southern region of Ethiopia. Int J Tuberc Lung Dis 14: 973–979.
Jackson C, Stagg H, Doshi A, Pan D, Sinha A, Batra R, Batra S, Abubakar I, Lipman M, 2017. Tuberculosis treatment outcomes among disadvantaged patients in India. Public Health Action 7: 134–140.
Ditah IC, Reacher M, Palmer C, Watson JM, Innes J, Kruijshaar ME, Luma HN, Abubakar I, 2008. Monitoring tuberculosis treatment outcome: analysis of national surveillance data from a clinical perspective. Thorax 63: 440–446.
Tobin-West CI, Isodje A, 2016. Quality and rural-urban comparison of tuberculosis care in Rivers State, Nigeria. Pan Afr Med J 24.
DeRiemer K, García-García L, Bobadilla-del-Valle M, Palacios-Martínez M, Martínez-Gamboa A, Small PM, Sifuentes-Osornio J, Ponce-de-León A, 2005. Does DOTS work in populations with drug-resistant tuberculosis? Lancet 365: 1239–1245.
Zhang H, Ehiri J, Yang H, Tang S, Li Y, 2016. Impact of community-based DOT on tuberculosis treatment outcomes: a systematic review and meta-analysis. PLoS One 11: e0147744.
Yin J, Yuan J, Hu Y, Wei X, 2016. Association between directly observed therapy and treatment outcomes in multidrug-resistant tuberculosis: a systematic review and meta-analysis. PLoS One 11: e0150511.
World Health Organization Communicable Diseases Cluster, 1999. What is DOTS?: A Guide to Understanding the WHO-recommended TB Control Strategy Known as DOTS. Geneva, Switzerland: World Health Organization.
Pungrassami P, Johnsen S, Chongsuvivatwong V, Olsen J, Sørensen H, 2002. Practice of directly observed treatment (DOT) for tuberculosis in southern Thailand: comparison between different types of DOT observers. Int J Tuberc Lung Dis 6: 389–395.
Dye C, Watt CJ, Bleed DM, Williams BG, 2003. What is the limit to case detection under the DOTS strategy for tuberculosis control? Tuberculosis 83: 35–43.
Jittimanee S, Vorasingha J, Mad-asin W, Nateniyom S, Rienthong S, Varma JK, 2009. Tuberculosis in Thailand: epidemiology and program performance, 2001–2005. Int J Infect Dis 13: 436–442.
Soonthorndhana A, Vorasiriamon Y, Theobald S, Smith H, 2004. Community Perceptions and Experiences of TB in Kanchanaburi, Thailand: A Gender Equity Analysis. Nakhon Pathom, Thailand: Institute for Population and Social Research, Mahidol University.
Padayatchi N, Daftary A, Naidu N, Naidoo K, Pai M, 2019. Tuberculosis: treatment failure, or failure to treat? Lessons from India and South Africa. BMJ Global Health 4: e001097.
Mahendradhata Y, Lestari T, Probandari A, Indriarini LE, Burhan E, Mustikawati D, Utarini A, 2015. How do private general practitioners manage tuberculosis cases? A survey in eight cities in Indonesia. BMC Res Notes 8: 564.
Anunnatsiri S, Chetchotisakd P, Wanke C, 2005. Factors associated with treatment outcomes in pulmonary tuberculosis in northeastern Thailand. Southeast Asian J Trop Med Public Health 36: 324–330.
Babalık A, Kılıçaslan Z, Kızıltaş Ş, Gencer S, Öngen G, 2013. A retrospective case-control study, factors affecting treatment outcomes for pulmonary tuberculosis in Istanbul, Turkey. Balkan Med J 30: 204.
Dooley KE, Lahlou O, Knudsen J, Elmessaoudi MD, Cherkaoui I, El Aouad R, 2011. Risk factors for tuberculosis treatment failure, default, or relapse and outcomes of retreatment in Morocco. BMC Public Health 11: 140.
Kritski AL, de Jesus LSR, Werneck-Barroso E, Vieira MAMS, Andrade MK, Haffner A, Riley LW, 1997. Retreatment tuberculosis cases: factors associated with drug resistance and adverse outcomes. Chest 111: 1162–1167.
Rifat M, Hall J, Oldmeadow C, Husain A, Hinderaker SG, Milton AH, 2015. Factors related to previous tuberculosis treatment of patients with multidrug-resistant tuberculosis in Bangladesh. BMJ Open 5: e008273.
Rifat M, Milton AH, Hall J, Oldmeadow C, Islam MA, Husain A, Akhanda MW, Siddiquea BN, 2014. Development of multidrug resistant tuberculosis in Bangladesh: a case-control study on risk factors. PLoS One 9: e105214.
Balasubramanian V, Oommen K, Samuel R, 2000. DOT or not? Direct observation of anti-tuberculosis treatment and patient outcomes, Kerala State, India. Int J Tuberc Lung Dis 4: 409–413.
Nour El Din M, Elhoseeny T, Mohsen A, 2013. Factors affecting defaulting from DOTS therapy under the national programme of tuberculosis control in Alexandria, Egypt. East Mediterr Health J 19: 107–113.
Xu W, Lu W, Zhou Y, Zhu L, Shen H, Wang J, 2009. Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study. BMC Health Serv Res 9: 169.
Lamsal D, Lewis O, Smith S, Jha N, 2009. Factors related to defaulters and treatment failure of tuberculosis patients in the DOTS program in the Sunsari district of Eastern Nepal. SAARC J Tuber Lung Dis HIV/AIDS 6: 25–30.
Bam TS, Gunneberg C, Chamroonsawasdi K, Bam D, Aalberg O, Kasland O, Shiyalap K, Srisorrachatr S, 2006. Factors affecting patient adherence to DOTS in urban Kathmandu, Nepal. Int J Tuberc Lung Dis 10: 270–276.
McLaren ZM, Milliken AA, Meyer AJ, Sharp AR, 2016. Does directly observed therapy improve tuberculosis treatment? More evidence is needed to guide tuberculosis policy. BMC Infect Dis 16: 537.
Vijay S, Kumar P, Chauhan LS, Vollepore BH, Kizhakkethil UP, Rao SG, 2010. Risk factors associated with default among new smear positive TB patients treated under DOTS in India. PLoS One 5: e10043.
Lorent N, Choun K, Malhotra S, Koeut P, Thai S, Khun KE, Colebunders R, Lynen L, 2015. Challenges from tuberculosis diagnosis to care in community-based active case finding among the urban poor in cambodia: a mixed-methods study. PLoS One 10: e0130179.
Dobler CC, Korver S, Batbayar O, Oyuntsetseg S, Tsolmon B, Wright C, Solongo B, Marais BJ, 2015. Success of community-based directly observed anti-tuberculosis treatment in Mongolia. Int J Tuberc Lung Dis 19: 657–662.
Marais BJ, Loennroth K, Lawn SD, Migliori GB, Mwaba P, Glaziou P, Bates M, Colagiuri R, Zijenah L, Swaminathan S, 2013. Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts. Lancet Infect Dis 13: 436–448.
Rao VK, Lademarco EP, Fraser VJ, Kollef MH, 1998. The impact of comorbidity on mortality following in-hospital diagnosis of tuberculosis. Chest 114: 1244–1252.
Perrin F, Woodward N, Phillips P, McHugh T, Nunn A, Lipman M, Gillespie S, 2010. Radiological cavitation, sputum mycobacterial load and treatment response in pulmonary tuberculosis. Int J Tuberc Lung Dis 14: 1596–1602.
Palaci M, Dietze R, Hadad DJ, Ribeiro FKC, Peres RL, Vinhas SA, Maciel ELN, do Valle Dettoni V, Horter L, Boom WH, 2007. Cavitary disease and quantitative sputum bacillary load in cases of pulmonary tuberculosis. J Clin Microbiol 45: 4064–4066.
Pradipta I, Van’t Boveneind-Vrubleuskaya N, Akkerman O, Alffenaar J, Hak E, 2019. Predictors for treatment outcomes among patients with drug-susceptible tuberculosis in the Netherlands: a retrospective cohort study. Clin Microbiol Infect 25: 761.
Pradipta IS, van’t Boveneind-Vrubleuskaya N, Akkerman OW, Alffenaar J-WC, Hak E, 2019. Treatment outcomes of drug-resistant tuberculosis in the Netherlands, 2005–2015. Antimicrob Resist Infect Control 8: 115.
Department of Medical Services, Ministry of Public Health, 2018. Clinical Practice Guideline (CPG) of Tuberculosis Treatment in Adult. Nonthaburi, Thailand: Ministry of Public Health.
Harries A, Banda H, Boeree M, Welby S, Wirima J, Subramanyam V, Maher D, Nunn P, 1998. Management of pulmonary tuberculosis suspects with negative sputum smears and normal or minimally abnormal chest radiographs in resource-poor settings. Int J Tuberc Lung Dis 2: 999–1004.
Ralph AP, Ardian M, Wiguna A, Maguire GP, Becker NG, Drogumuller G, Wilks MJ, Waramori G, Tjitra E, Kenagalem E, 2010. A simple, valid, numerical score for grading chest x-ray severity in adult smear-positive pulmonary tuberculosis. Thorax 65: 863–869.
Javaid A, Ullah I, Masud H, Basit A, Ahmad W, Butt Z, Qasim M, 2018. Predictors of poor treatment outcomes in multidrug-resistant tuberculosis patients: a retrospective cohort study. Clin Microbiol Infect 24: 612–617.